Therapeutic potential of chemically modified siRNA: Recent trends.

about

VEGF siRNA delivered by polycation liposome-encapsulated calcium phosphate nanoparticles for tumor angiogenesis inhibition in breast cancer.Stimuli-responsive oligonucleotides in prodrug-based approaches for gene silencing.

P2860

Q41531949-3F81AA22-F331-41CE-9DF7-B2F32776A8E7 Q51742560-18C8385B-B59D-4368-878A-A6A74BE90D89

P2860

Therapeutic potential of chemically modified siRNA: Recent trends.

Item

http://www.wikidata.org/entity/Q39221358

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Therapeutic potential of chemically modified siRNA: Recent trends.

@en

Therapeutic potential of chemically modified siRNA: Recent trends.

@nl

type

Item

label

Therapeutic potential of chemically modified siRNA: Recent trends.

@en

Therapeutic potential of chemically modified siRNA: Recent trends.

@nl

prefLabel

Therapeutic potential of chemically modified siRNA: Recent trends.

@en

Therapeutic potential of chemically modified siRNA: Recent trends.

@nl

P1476

Therapeutic potential of chemically modified siRNA: Recent trends.

@en

P2093

Daniel Mutisya

http://www.w3.org/2001/XMLSchema#string

Kasturi Ranganna

http://www.w3.org/2001/XMLSchema#string

Ramasamy Thilagavathi

http://www.w3.org/2001/XMLSchema#string

Sandhya Prakash

http://www.w3.org/2001/XMLSchema#string

P2860

Small interfering RNAs containing full 2'-O-methylribonucleotide-modified sense strands display Argonaute2/eIF2C2-dependent activity.

Introduction of a Chimeric Chalcone Synthase Gene into Petunia Results in Reversible Co-Suppression of Homologous Genes in trans

2′-Azido RNA, a Versatile Tool for Chemical Biology: Synthesis, X-ray Structure, siRNA Applications, Click Labeling

Amides are excellent mimics of phosphate internucleoside linkages and are well tolerated in short interfering RNAs

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

Delivery of RNAi Therapeutics to the Airways-From Bench to Bedside

RNA interference-based nanosystems for inflammatory bowel disease therapy

Structural basis for overhang-specific small interfering RNA recognition by the PAZ domain

5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.

Chemical modification: the key to clinical application of RNA interference?

P304

665-678

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CBDD.12993

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chelliah Selvam

P577

2017-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28378934

http://www.w3.org/2001/XMLSchema#string

P932

5935465

http://www.w3.org/2001/XMLSchema#string

Therapeutic potential of chemically modified siRNA: Recent trends.

about

P2860

P2860

Therapeutic potential of chemically modified siRNA: Recent trends.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932